|
Volumn 16 Suppl, Issue , 1998, Pages 59-60
|
How do you measure "success" in a biotechnology company?
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
BIOTECHNOLOGY;
DRUG INDUSTRY;
ECONOMIC ASPECT;
ECONOMICS;
FINANCIAL MANAGEMENT;
INVESTMENT;
PHASE 3 CLINICAL TRIAL;
RESEARCH;
BIOTECHNOLOGY;
CAPITAL FINANCING;
CLINICAL TRIALS, PHASE III;
DRUG INDUSTRY;
ECONOMIC COMPETITION;
INVESTMENTS;
RESEARCH;
|
EID: 0032065924
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/5435 Document Type: Article |
Times cited : (3)
|
References (0)
|